Press Releases

David Pass and Adam Hameed bring decades of business development, strategy, and industry experience to Glooko's leadership team

PALO ALTO, Calif., May 21, 2024 /PRNewswire/ -- Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma and medical partners, proudly announces the appointments of Dr. David Pass and Adam Hameed as Presidents of Life Sciences and Connected Care, respectively.

... (continue reading...)

Trees are essential to the long-term sustainability of our business and the partners who work with us to take steps to do the right thing for our planet.

Angela Tejada-Chavez, Matt Silveira and Molly Haragan

NORTHAMPTON, MA / ACCESSWIRE / May 21, 2024 / Angela Tejada-Chavez, Head of Sustainable Sourcing, Cocoa; Molly Haragan, Sr. Manager, Responsible Sourcing; Matt Silveira, Manager, Environmental Sustainability

Key Takeaways:

• In 2023, Hershey expanded its partnership with... (continue reading...)

STONECREST, Ga., May 21, 2024 /PRNewswire/ -- Hundreds gathered as New Birth Senior Pastor Dr. Jamal Harrison Bryant and a host of elected officials and community leaders broke ground to commemorate Stonecrest's first mini-home community on Saturday, May 18. The Benison ATL is a transformative mixed-use development that will occupy 35-acres of New Birth's property and feature 120 mini-homes in its initial phase of construction – reshaping the landscape of affordable... (continue reading...)

SAN JOSE, Calif., May 21, 2024 /PRNewswire/ --On May 9, 2024, construction owners from the Wisconsin and Illinois areas gathered to network, establish valuable connections, and spark new partnerships at the inaugural CO Summit 2024. Co-organized by Lumber, the event was a tremendous success, with 23 companies from Wisconsin and Illinois showcasing their offerings, attendees had ample chances to connect with industry peers, share ideas, and explore potential... (continue reading...)

Company Announcement

• Genmab has completed acquisition of ProfoundBio for USD 1.8 billion in cash
• Acquisition gives Genmab worldwide rights to three candidates in clinical development, including rinatabart sesutecan (Rina-S), plus ProfoundBio’s novel antibody-drug conjugate technology platforms  

COPENHAGEN, Denmark; May 21, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that it has completed its acquisition of ProfoundBio, Inc., a clinical-stage biotechnology... (continue reading...)